Suven Pharmaceuticals and Cohance Lifesciences announce merger
In a significant development in the pharmaceutical industry, Suven Pharmaceuticals Limited (Suven) and Cohance Lifesciences Limited (Cohance) have announced a proposed scheme of amalgamation, marking a pivotal moment in the journey of both companies. The merger is set to enhance Suven’s standing in the Contract Development and Manufacturing Organization (CDMO) space, aiming for leadership by […]